Incidence of Dyslipidemia as a public health issue within the provinces of Panamá, Herrera and Los Santos in patients of the General Medicine consultation at the Pueblo Nuevo Health Center, Hospital Dr. Gustavo Nelson Collado and Hospital Joaquín Pablo Franco: Clinical record review during february 2024.
DOI:
https://doi.org/10.56294/shp2025377Keywords:
Dyslipidemias, cardiovascular risk, atherosclerosis, education, tobacco, substance abuse, onsequences, efficacyAbstract
The main objective of this research is to raise awareness of the high frequency, risks and consequences of lipid disorders. This is a public health problem we are currently facing in our modern society. However, it is a problem whose relevance is not adequately recognized. The consequences of dyslipidemias are concerning, and when left untreated, they are detrimental to the patient's health and quality of life.
Increased cardiovascular risk, early development of atherosclerosis and hepatic steatosis are just some of the consequences of sustained high lipid levels over time, as well as, the consumption of tobacco products and other substances. Therefore, patient information and education is of crucial interest to curb the development of the disease.
We have gathered data from several institutions to determine the prevalence of dyslipidemias in different areas of the country. Additionally, our aim is to educate the patient as to the risks and consequences that exist and the importance of adherence to treatment in order to obtain maximum efficacy of the treatment and to minimize these risks and consequences.
References
1. Wiener C, Fauci AS, Hauser SL, Longo DL, J. Larry Jameson, Kasper DL, et al. Harrison’s Principles of Internal Medicine Self-Assessment and Board Review, 20th Edition. McGraw Hill Professional; 2021.
2. Sonia KF, Renata DGK. Puesta al día en el manejo de las dislipidemias. Revista Médica Clínica Las Condes [Internet]. 2012 Nov 1;23(6):681–7. Available from: https://www.elsevier.es/es-revista-revista-medica-clinica-las-condes-202-articulo-puesta-al-dia-el-manejo-S0716864012703681
3. Dr. Pablo H. A Comprehensive Review on Metabolic Syndrome - OPD-Salud de Tlaxcala. Cardiology Research and Practice. 2014;2014:1–21.
4. World Health Organization. (2020). Global Burden of Disease Study 2019. GBD Results Tool. Recuperado de https://gbd2019.healthdata.org/gbd-results-tool.
5. American Heart Association. (2018). 2018 AHA/ACC Cholesterol Treatment Guidelines. Circulation, 139(25), e1082–e1143. https://doi.org/10.1161/CIR.0000000000000625.
6. Villa, M. L. (n.d.). Estudio Descriptivo: Prevalencia de Dislipidemia en Adultos de 40 - 64 Años, Cuenca - Ecuador, Enero a Julio 2014. https://docs.bvsalud.org/biblioref/2019/06/999307/estudio-descriptivo-prevalencia-de-dislipidemia-en-adultos-de-4_zCrAn1d.pdf
7. Pallarés-Carratalá, V., Pascual-Fuster, V., & Godoy-Rocati, D. V. (2015). Dislipidemia y riesgo vascular. Una revisión basada en nuevas evidencias. Medicina de Familia. SEMERGEN, 41(8), 435-445. https://doi.org/10.1016/j.semerg.2014.10.015
8. Ministerio de Salud Dirección Nacional de Planificación. (2015). Taller Análisis de Situación de Salud Panamá 2015. Recuperado de https://www.minsa.gob.pa/sites/default/files/publicaciones/presentacion_aliniamiento_estrategico.pdf
9. López-Jaramillo, P., Sánchez, R. A., Díaz, M., & Cobos, L. (2017). Dislipidemia aterogénica en Latinoamérica: prevalencia, causas y tratamiento. Un consenso. SciELO. Recuperado de https://www.scielo.org.mx/scielo.php?pid=S0188-21982017000200057&script=sci_abstract&tlng=es
10. Gómez-Dantés, H., Fullerton, T., Bärnighausen, T., Correa, J. C., & Gupta, S. (2017). Dislipidemia aterogénica en Latino América: prevalencia, causas y tratamiento. SciELO - Scientific Electronic Library Online. Recuperado de http://ve.scielo.org/scielo.php?pid=S1690-31102017000200006&script=sci_arttext
11. Caja de Seguro Social. (2021, 27 de octubre). Dislipidemia y su relación con las enfermedades cardiovasculares. CSS Noticias. Recuperado de https://prensa.css.gob.pa/2021/10/27/dislipidemia-y-su-relacion-con-las-enfermedades-cardiovasculares/
12. Instituto Nacional de Salud Pública. (s.f.). Dislipidemias. Recuperado de https://www.insp.mx/resources/images/stories/Produccion/pdf/110311_cp1.pdf.
Published
Issue
Section
License
Copyright (c) 2026 Beatriz Alexandra Lobo Rincón , Darcy Tatiana Perdomo , Maria Andreina Pulido Montes , Adriana Paola Casadiegos Buitrago (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
